Gynaecological sarcomas are a rare but important group of gynaecological tumours. The commonest types are leiomyosarcomas and endometrial stromal sarcomas arising from the uterus. Surgery for all gynaecological sarcomas is carried out by the highly experienced gynaecological oncology team which treats all gynaecological cancers within the North London Cancer Network. Chemotherapy and radiotherapy is given by the sarcoma oncologist, who regularly attends the weekly gynaecological oncology MDT meeting to discuss cases.

Surgeons

Dhivya_Chandra.jpg

I am a consultant gynaecological oncologist and Clinical Lead for surgical gynae-oncology at University College London Hospital.

I completed my undergraduate training at St Bartholomew's and the Royal London School of Medicine. I trained in Obstetrics and Gynaecology in London and the East Midlands. Following my research training, I completed my subspecialty fellowship in gynaecological oncology at the Royal London and Royal Marsden Hospitals.

My practice encompasses the comprehensive surgical management of gynaecological malignancies, and I am the lead for robotic surgery in gynae-oncology at UCLH,

NicolaMacdonald resize.jpgI trained in St. Mary's Hospital, London and completed an MD (University of London) in gynaecological oncology researching the genetic basis of endometrial cancers.  I am the Clinical Lead for Gynaecological Oncology within UCLH and I am also the lead clinician for paediatric and adolescent gynaecological cancers. I have an interest in the laparoscopic treatment of gynaecological cancers. I am an accredited colposcopist and a member of the British Society of Colposcopists and Cytopathologists.  I also belong to the British and European Societies of Gynaecological Oncology.

View full consultant profile

Oncologists

Mabs Ahmed 2 resize.jpg

I completed my clinical training at St Bartholomew’s and University College London Hospitals. I completed a PhD at the Institute of Cancer Research and the Royal Marsden Hospital which looked at the genes that predispose patients to prostate cancer.

I now specialise in the treatment of soft tissue and bone sarcomas using chemotherapy and radiotherapy. I work in the one of the largest sarcoma centres in Europe and I am one of the leading experts in the UK in the treatment of soft tissue sarcoma and bone sarcoma (all body sites except brain) using technical photon and proton radiotherapy. I have pioneered a new innovative practice changing radiotherapy technique in the treatment of soft tissue and bone sarcomas for patients who cannot  have surgery. This technique uses the latest technology which allows the delivery of high doses of radiotherapy that can offer long term control for large soft tissue and bone tumours which were previously untreatable with minimal side effects. This technique can be used in sarcomas all over the body but in particular for inoperable intra-abdominal and pelvic sarcomas. This technique is currently under development for a national clinal trial in the UK and internationally (HD Sarc) and is currently only available at UCLH. I also offer re-irradiation for sarcomas that have had radiotherapy previously or have been caused by previous radiotherapy.

I also have a special interest in breast sarcoma including phyllodes tumours and angiosarcoma of the breast. I was one of the main authors in the UK national phyllodes guidelines and lead nationally for improvement outcomes of breast sarcomas.

I am a strong advocate in the holistic care of cancer management with focus on diet, exercise and emotional wellbeing. A diagnosis of cancer can often bring a shock to patients’ lives and therefore a reflection and adjustment on individual lifestyle factors in our busy and stressful lives is critical in comprehensive cancer management. Many diseases in our population are due to the contribution of environment, lifestyle and food choices.

View full consultant profile

IRP_2_420a GF resize.jpg

I was educated and started my training in Internal Medicine in Greece. I also conducted my PhD at University of Ioannina in angiogenesis and proteolysis in cancer of unknown primary site. I completed my specialist training in Oncology at the Royal Marsden Hospital in London during a 3 year fellowship. I followed an academical career in Aristotle University of Thessaloniki in Greece and I led the Medical Oncology Department during my last year of my stay there. In 2015 I was appointed as a Consultant Medical Oncologist at UCLH and I am exclusively treating patients with bone and soft tissue sarcomas with systemic treatment within the London Sarcoma Service.

I look after patients with tenosynovial giant cell tumours (TGCT) and lead on this pathway across the London Sarcoma Service. I am working towards setting up a dedicated clinic for TGCT patients who are considered for medical management. I have a strong interest in international and national clinical trials across multiple tumour types and more recently in sarcoma, acting as principal and co-investigator for a number of them.  I was previously involved in early clinical trials, both in the UK and Greece, with novel agents, and have experience in pharmacokinetics and pharmacodynamic models. 

I have published over 100 articles in peer-reviewed journals in clinical and translational research, and I regularly teach and lecture in the management of sarcomas. I also hold an honorary clinical senior lectureship contract with UCL and I contribute to the teaching of medical students. I am member of several scientific organisations including British Sarcoma Group, EORTC Soft Tissue and Bone Sarcoma Group, ESMO, ASCO, HeSMO etc.

View full consultant profile

 

Histopathologists

I am a FA resize.jpgConsultant Histopathologist with a special interest in bone and soft tissue tumour: diagnostic aspects and molecular genetics. I have worked in a large tertiary hospital in Sao Paulo, Brazil as a consultant for 12 years before taking the current post at the Royal National Orthopaedic Hospital (RNOH) in 2010. I completed my Ph.D. in 2007 with focus in molecular genetics of sarcomas, and since them my research interest includes molecular aspects in the diagnosis and treatment of sarcomas. I am the clinical lead for Molecular Pathology at the histopathology department at RNOH and Honorary Senior Lecturer at University College London, Cancer Institute.

View full consultant profile

rupali-arora.jpgI am a full time NHS Consultant Pathologist. I am the lead Gynae-Onc Pathologist at UCLH. I  take part in specialist reporting of gynaecological pathology and urological pathology specimens.

I share the gynae oncology work load, which includes the reporting of UCLH pathology specimens, frozen sections  as well as London cancer network and referral second opinion cases from UK and abroad . I perform both coroners and hospital postmortems. I regularly supervise  and conduct lectures for histopathology trainees, biomedical scientists and medical students. I sit on the pathology specialist training comittee of the London deanery and pathology sub-committe of UCL . I am invovlved in assesing year 3 medical students , Bloomsbury foundation year applicants and  national histopathology ST 1 applicants .I sit on the ARCP and OPSE panels to assess  the London deanery histopathology trainees. I am part of the  London Quality Assurance Team for Cervical Screening. As part of my continued professional development I take part in the gynaecological pathology and urological pathology EQA schemes.

View full consultant profile

Adrienne.jpgI am the clinical lead for the diagnostic pathology service for the London Sarcoma Service undertaking the NHS service work at the Royal National Orthopaedic Hospital NHS Trust. My research is based in the NHS Histopathology Department in Stanmore, and in the Paul O'Gorman Cancer Institute, Huntley Street, UCL.

Making a correct diagnosis is pivotal in deciding the best treatment for a patient. Cancer is caused by genetic alterations in cells and we can use these genetic changes to diagnose tumours accurately. Over the last 10 years, my research has focused on improving the way that we provide diagnoses for patients. In collaboration with my NHS colleagues we have translated this research into clinical practice and are using our findings every day in clinical practice.

View full consultant profile

IRP_2_417a GF resize.jpgI am a full-time Consultant Histopathologist with exclusive interest in the biology and pathology of bone and soft tissue tumours.

View full consultant profile

Giorgia Trevisan.jpgI am a consultant histopathologist at University College London Hospital (UCLH), where I specialise in gynaecopathology. I earned my medical degree from the University of Udine in Italy and completed my postgraduate training in London’s teaching hospitals. My experience was further developed at major tertiary centres, including the Royal Marsden Hospital and The Royal London Hospital, as well as through visits to international institutions such as Harvard Medical School and Vancouver General Hospital.

In addition to my clinical role, I am actively involved in collaborative gynaecologic oncology research and national clinical trials. Since 2016, I have served as the Lead Histopathologist for the NHS England cervical screening programme.

Radiologists

I am a consultant radiologist at UCLH. I have a particular interest in the imaging of abdominal sarcoma as well as disorders of the upper GI tract, liver, biliary system and the pancreas.